VENHOFF, Nils, SCHMIDT, Wolfgang Andreas, LAMPRECHT, Peter, TONY, Hans-Peter, APP, Christine, SIEDER, Christian, LEGELER, Carolin, JENTZSCH, Claudia und THIEL, Jens, 2021. Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial. Freiburg: Universität.

Venhoff, N., Schmidt, W.A., Lamprecht, P., Tony, H.-P., App, C., Sieder, C., Legeler, C., Jentzsch, C., Thiel, J., 2021. Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial. Universität, Freiburg. https://doi.org/10.1186/s13063-021-05520-1

Venhoff, N., Schmidt, W. A., Lamprecht, P., Tony, H.-P., App, C., Sieder, C., Legeler, C., Jentzsch, C., & Thiel, J. (ca. 2021). Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial [Cd]. Universität. https://doi.org/10.1186/s13063-021-05520-1

Venhoff N, Schmidt WA, Lamprecht P, Tony H-P, App C, Sieder C, Legeler C, Jentzsch C, Thiel J (2021) Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial. Universität, Freiburg

Venhoff, Nils/ Schmidt, Wolfgang Andreas/ Lamprecht, Peter/ Tony, Hans-Peter/ App, Christine/ Sieder, Christian/ Legeler, Carolin/ Jentzsch, Claudia/ Thiel, Jens, Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial, Freiburg 2021.